Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.

Mutation research - 1 Jan 2000

Zgheib Nathalie K, Shamseddine Ashraf A, Geryess Eddy, Tfayli Arafat, Bazarbachi Ali, Salem Ziad, Shamseddine Ali, Taher Ali, El-Saghir Nagi S

Abstract excerpt

Changes in the activity of drug metabolizing enzymes (DMEs) are potentially associated with cancer risk. This relationship is attributed to their involvement in the bioactivation of multiple procarcinogens or the metabolism of multiple substrates including an array of xenobiotics and environmental carcinogens. 326 Lebanese women of whom 99 were cancer free (controls) and 227 were diagnosed with breast cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Lobular

Share to Cytochrome P-450 CYP2E1

Share to Genes, erbB-2

Share to Lebanon

Share to Neoplasms, Hormone-Dependent

Share to Progesterone

Source

Identifiers

PMID: 23628324
DOI: 10.1016/j.mrfmmm.2013.04.004

Genes

NAT2
GSTM1
GSTP1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.PMID 23628324Read ↗

CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese.Semantic proximity Read ↗

Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?Semantic proximity Read ↗

Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.Semantic proximity Read ↗

Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer.Semantic proximity Read ↗

Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases.Semantic proximity Read ↗

Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.Semantic proximity Read ↗

Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.Semantic proximity Read ↗

Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.Semantic proximity Read ↗

Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.Semantic proximity Read ↗

Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women.Semantic proximity Read ↗

Genetic polymorphism of the glutathione S-transferase M1 and T1 genes in three distinct Arab populations.Semantic proximity Read ↗

Distribution of xenobiotic metabolising enzyme genotypes in different Tunisian populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.